Vorinostat Plus Lenalidomide and Dexamethasone or Lenalidomide Plus Dexamethasone in Multiple Myeloma Patients Who Experience Biochemical Relapse During Lenalidomide Maintenance Therapy (ZLd_Ld)
This study has been withdrawn prior to enrollment.
Information provided by (Responsible Party):
Tiziana Marangon, University of Turin, Italy
First received: December 16, 2011
Last updated: December 10, 2013
Last verified: December 2013
No Study Results Posted on ClinicalTrials.gov for this Study
Study was withdrawn before participants were enrolled.
|Study Status:||This study has been withdrawn prior to enrollment.|
|Estimated Study Completion Date:||February 2017|
|Estimated Primary Completion Date:||February 2014 (Final data collection date for primary outcome measure)|